Sphingolipids in Alzheimer's disease, how can we target them?
Simone M. Crivelli, Caterina Giovagnoni, Lars Visseren, Anna-Lena Scheithauer, Nienke M. de Wit, Sandra den Hoedt, Mario Losen, Monique Mulder, Jochen Walter, Helga E. de Vries, Erhard Bieberich, Pilar Martínez‐Martínez
Topics & Concepts
SphingolipidCeramideNeuroscienceBiologyDiseaseSecond messenger systemCell biologySignal transductionMedicineBiochemistryInternal medicineApoptosisSphingolipid Metabolism and SignalingLipid Membrane Structure and BehaviorAlzheimer's disease research and treatments